Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of “palateau”

The first-line therapy of metastatic renal cell carcinoma (mRCC) has revolutionized with the approval of immune checkpoint inhibitors (ICIs) in combination with or without tyrosine kinase inhibitors (TKIs). The choice among the many different immuno-combinations (ICI-ICI or ICI-TKI) is challenging d...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Pasquale Rescigno, Giuseppe Luigi Banna, Sebastiano Buti
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2024-12-01
Schriftenreihe:	Human Vaccines & Immunotherapeutics
Schlagworte:	Renal cell carcinoma immune checkpoint inhibitor immuno-combination immunotherapy survival outcomes
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2351669
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!